We're proud to share that James Lovett, Myonex CEO, has been nominated for the Life Sciences & Healthcare CEO category at the 2024 Philadelphia Alliance for Capital and Technologies (PACT) Awards. Starting as a small team in Norristown, PA, Myonex has grown into a global leader with over 400 employees. This growth has been fueled by our unwavering commitment to partnering with our clients to enhance their clinical trials and patient care worldwide. Our recent expansions, including the acquisitions of Creapharm, a Myonex company, and Saveway Compounding Pharmacy, a Myonex company, highlight our continued dedication to being the fastest, most flexible and reliable partner in the clinical trial industry. We’re excited to celebrate this milestone—join us at the awards ceremony on May 21st! RSVP here: https://bit.ly/4d9I67R. #PACTAwards #HealthcareLeadership #Myonex #Innovation #ClinicalTrials #ClinicalTrialSupply
🏆 EA Finalist Spotlight: James Lovett, CEO of Myonex, is nominated in the Life Sciences & Healthcare CEO category at the 2024 Awards. Discover their impactful work: https://bit.ly/3WjUegF Be part of the celebration! RSVP for the awards ceremony and networking event on 5/21 here: https://bit.ly/4d9I67R
Such an honor to be coached by James! Well deserved!
James Lovett is an obvious choice! 🚀
Congratulations on this well deserved recognition!
Amazing, congrats to our great inspiring CEO and leader James Lovett! #TeamMyonex
Congratulations on the recognition!
Congratulations James Lovett !
Kudos James!
Congratulations, James Lovett for the Win! ,
Congrats James Lovett! Bravo!!
Marketing Manager at Myonex
2moI'm proud to be part of Myonex, where our leaders are genuinely committed to our team, clients, and the patients our clients' trials support. Congratulations to James Lovett!